leadf
logo-loader
viewMetal Tiger PLC

Metal Tiger invests US$1.5mln into Kalahari Metals

Following the latest funding round, Metal Tiger will own just over 62% of the copper exploration business as well as holding a 2% net smelter royalty

drilling machinery onsite

Natural resources investor Metal Tiger PLC (LON:MTR) is ploughing a further US$1.5mln into Kalahari Metals, giving it just over 62% of the Botswana-focused copper explorer.

Metal Tiger will also receive a 2% net smelter royalty over Kalahari’s seven wholly-owned licences.

Any further investment up to US$500,000 must be at least at the same valuation as the current round for the royalties to be maintained.

The cash will be used to fund exploration drilling programmes at the Kitlanya East, Kitlanya West and Okavango projects on the Kalahari Copper Belt.

Metal Tiger chief executive Michael McNeilly said: “In the context of our expectation of an increasing global requirement for copper production, and therefore exploration, we expect the Kalahari Copper Belt to become an increasingly more valuable area to be situated and are delighted to increase our interest in the area.”

Quick facts: Metal Tiger PLC

Price: 27 GBX

AIM:MTR
Market: AIM
Market Cap: £41.38 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Metal Tiger PLC named herein, including the promotion by the Company of Metal Tiger PLC in any Content on the Site, the Company receives from...

FOR OUR FULL DISCLAIMER CLICK HERE

Morning report: FTSE falls as traders get back to their desks

The FTSE is lower after a long weekend despite UK factory output rising by the fastest pace in more than six years, albeit from a low level as businesses begin to get back to work.  Movers and shakers include AstraZeneca (LON:AZN) which has received EU approval for Imfinzi which is to...

2 weeks, 5 days ago

2 min read